WHO/UNICEF/UNFPA JOINT STATEMENT

Appropriate Storage and Management

of Oxytocin – a Key Commodity

for Maternal Health

WHO/UNICEF/UNFPA have issued a joint statement regarding the management of oxytocin, a medicine essential to the prevention and treatment of postpartum haemorrhage as well as other indications. The management of oxytocin is critical to ensuring that it is effective when it reaches women, including procurement, cold chain management and clear and consistent labelling. Please read the link to the joint statement for specific details.

https://apps.who.int/iris/bitstream/handle/10665/311524/WHO-RHR-19.5-eng.pdf

Lisa Hedman
World Health Organization
Geneva, Switzerland
Web: www.who.int/medicines/en/
Follow WHO on Facebook, Twitter, YouTube, Instagram